Related references
Note: Only part of the references are listed.Impact of Drug Metabolism/Pharmacokinetics and its Relevance Considering Traditional Medicine-based Anti-COVID-19 Drug Research
Da-Cheng Hao et al.
CURRENT DRUG METABOLISM (2022)
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
Ke Hu et al.
PHYTOMEDICINE (2021)
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Xiaofei Chen et al.
ACTA PHARMACEUTICA SINICA B (2021)
New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment
Zhao Tianyu et al.
Aging-US (2021)
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
Zhonglei Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
Xiaowei Gong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases
Pan Shen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19 A systematic review and network meta-analysis
Xiaozheng Wu et al.
MEDICINE (2021)
Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
Ming Liu et al.
INTEGRATIVE MEDICINE RESEARCH (2021)
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
Xiao-fang Lan et al.
ACTA PHARMACOLOGICA SINICA (2021)
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
Shi-Bing Liang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2021)
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
Liu-Cheng Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Traditional and complementary medicine during COVID-19 pandemic
Shuvadeep Ganguly et al.
PHYTOTHERAPY RESEARCH (2020)
Molecular and functional resemblance of dexamethasone and quercetin: A paradigm worth exploring in dexamethasone-nonresponsive COVID-19 patients
Anil Pawar et al.
PHYTOTHERAPY RESEARCH (2020)
Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19
Qi-Dong Xia et al.
CELL PROLIFERATION (2020)